Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02625480
Title A Multi-Center Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-4)
Acronym ZUMA-4
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite Pharma, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | SWE | POL | NLD | ITA | FRA | ESP | DEU | CZE | CAN | BEL


No variant requirements are available.